Seroquel

Class action suit against Astrazeneca the manufacturers of Seroquel

MONTREAL, June 1 /CNW Telbec/ - Mr. François-Luc Lavallée, a 48 year-old citizen of Bois-des-Fillions, Québec, is the representative Plaintiff in a national class action claiming more than $100,000,000 in damages and interest on behalf of the entire plaintiff class from the multi-national company AstraZeneca. Mr. Lavallee has issued a claim by way of a class action on behalf of all citizens, in Canada, who took the antipsychotic medication Seroquel(R). Seroquel(R) is prescribed for various mental health problems such as schizophrenia and bi-polar disorder.

Mr. Lavallée alleges having developed, among other problems, Type II diabetes after having used this medication and he alleges AstraZeneca has failed to inform the public, health authorities and patients of the serious health risks associated with this medication.

Seroquel(R) has been prescribed to more than 8 million people across the globe. This drug is a sales leader in the atypical antipsychotic pharmaceutical market in the United States and in Canada. The plaintiff class is estimated at thousands of persons. Many legal actions have been filed in the United States and in Canada, namely in Alberta, and British Columbia alleging similar claims.

Mr. Lavallée is represented by Lauzon Bélanger, a prominent class action firm in Canada, which works in close collaboration with McNally Cuming Raymaker who represents claimants from Alberta, and British Columbia, as well as Roy Elliott Kim O'Connor who represents class members in Ontario.

All persons interested by this class action request may consult the complete text of the motion on Lauzon Bélanger's Web site at www.lauzonbelanger.qc.ca or contact the firm's Member Services by e-mail to serviceauxmembres@lauzonbelanger.qc.ca or by phone at 514-287-1000 or 1-800-287-8587.

For Ontario inquiries, please contact REKO LLP at www.reko.ca , by e-mail to info@reko.ca or by phone at 416-362-1989.

In Western Canada, please contact McNally Cuming Raymaker, at www.mcnallycuming.com, by e-mail to rfogel@mcnallycuming.com, or by phone at 1-800-682-2480.

/CONTACT: Anna Vetere, director, Lauzon Bélanger inc., (514) 287-1000, 1-800-287-8587

(END) Dow Jones Newswires